Early Career Researcher Awards
Forecasted
Early Career Researcher Awards support emerging cancer immunotherapy scientists pursuing bold research ideas, with resources and connections to advance treatments and develop future leaders.
Browse similar grants
Funder: Parker Institute for Cancer Immunotherapy
Due Dates (Anticipated): January 2027 (application deadline)
Funding Amounts: $23.9 million+ awarded across 63 awards since 2016
Summary: Supports emerging researchers pursuing bold ideas in cancer immunotherapy.
Key Information: The awards are for early-career researchers in cancer immunotherapy.
Description
The Parker Institute for Cancer Immunotherapy launched its Early Career Researcher Awards in 2016 to support emerging scientists working to advance cancer immunotherapy. The awards encompass Parker Scholars, Parker Bridge Fellows and Parker Senior Fellows. The institute encourages ambitious questions, risk-taking and new thinking that could transform immunotherapy treatments.
Alongside financial support, awardees receive access to tools and technologies, clinical-trial data and pre-published papers. They can also connect with leading researchers and peers across the institute’s network. The program aims to develop the next generation of scientific leaders while advancing cancer immunotherapy research.
